Literature DB >> 19237208

HDL-associated factors provide additional prognostic information for coronary artery disease as determined by multi-detector row computed tomography.

Ryoko Mitsutake1, Shin-ichiro Miura, Bo Zhang, Keijiro Saku.   

Abstract

BACKGROUND: A significant relationship has been noted between the lipid profile and atherosclerotic coronary artery disease (CAD) using invasive coronary angiography. We tested the hypothesis that the severity of CAD as determined by a non-invasive method, multi-detector row computed tomography (MDCT), is also associated with lipidemic factors. METHODS AND
RESULTS: The subjects included 195 consecutive patients who underwent coronary angiography using MDCT because of suspected CAD. The number of significantly stenosed vessels (VD) as evaluated by MDCT, platelet-activating factor acetylhydrolase (PAF-AH), free cholesterol (FC), phospholipid (PL), remnant-like lipoprotein particle-cholesterol (RLP-C), apolipoprotein (apo)-B, apo-C3, apo-E, and highly-sensitive C-reactive protein were determined. The subjects were divided into diabetes mellitus (DM) and non-DM groups. The HDL-associated PAF-AH level in the DM group was significantly lower than that in the non-DM group. The VD determined by MDCT was significantly associated with hypertension, administration of angiotensin II type 1 receptor blocker, high-density lipoprotein cholesterol (HDL-C), HDL-associated (H)-HDL, H-PL, H-FC and RLP-C. Multivariate analysis revealed that VD determined by MDCT was most closely correlated with HDL-C.
CONCLUSION: Lower levels of HDL-C may be an indicator for and provide additional information regarding the severity of CAD compared with other lipidemic factors. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237208     DOI: 10.1016/j.ijcard.2009.01.058

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  Flat-panel versus 64-channel computed tomography for in vivo quantitative characterization of aortic atherosclerotic plaques.

Authors:  Ibrahim Aboshady; Dianna D Cody; Evan M Johnson; Amir Gahremanpour; Deborah Vela; Kamal G Khalil; Herbert L Dupont; James T Willerson; L Maximilian Buja; Gregory W Gladish
Journal:  Int J Cardiol       Date:  2010-12-24       Impact factor: 4.164

2.  Regression of coronary plaque after coronary artery bypass graft.

Authors:  Yuhei Shiga; Shin-Ichiro Miura; Hiroaki Nishikawa; Ayumi Nakamura; Tadaaki Arimura; Ryoko Mitsutake; Atsushi Iwata; Keijiro Saku
Journal:  J Cardiol Cases       Date:  2012-02-01

3.  Associations Between High Levels of High-Density Lipoprotein Cholesterol and the Presence and Severity of Coronary Artery Disease in Patients Who Have Undergone Coronary Computed Tomography Angiography.

Authors:  Kohei Tashiro; Hiroko Inoue; Yuhei Shiga; Yohei Tsukihashi; Tomoki Imaizumi; Kenji Norimatsu; Yoshiaki Idemoto; Takashi Kuwano; Makoto Sugihara; Hiroaki Nishikawa; Yousuke Katsuda; Shin-Ichiro Miura
Journal:  J Clin Med Res       Date:  2020-11-03

4.  A Coronary Artery Calcium Score of Zero in Patients Who Have Undergone Coronary Computed Tomography Angiography Is Associated With Freedom From Major Adverse Cardiovascular Events.

Authors:  Yuhei Shiga; Joji Morii; Yoshiaki Idemoto; Kohei Tashiro; Yuiko Yano; Yuta Kato; Takashi Kuwano; Makoto Sugihara; Shin-Ichiro Miura
Journal:  J Clin Med Res       Date:  2020-09-21

5.  Effect of zinc supplementation on type 2 diabetes parameters and liver metallothionein expressions in Wistar rats.

Authors:  Xue Wang; Hongyan Li; Zhe Fan; Ya Liu
Journal:  J Physiol Biochem       Date:  2012-05-15       Impact factor: 4.158

6.  Ezetimibe Monotherapy Reduces Serum Levels of Platelet-Activating Factor Acetylhydrolase in Patients With Dyslipidemia.

Authors:  Kanako Tano; Yasunori Suematsu; Kohei Tashiro; Naoko Kumagai-Koyanagi; Yoshino Matsuo; Takashi Kuwano; Shin-Ichiro Miura
Journal:  J Clin Med Res       Date:  2019-10-04

7.  Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.

Authors:  Zheng Qin; Kuo Zhou; Yue-Ping Li; Jian-Long Wang; Wan-Jun Cheng; Cheng-Ping Hu; Chao Shi; Hua He; Yu-Jie Zhou
Journal:  Cardiovasc Diabetol       Date:  2019-01-28       Impact factor: 9.951

8.  Association Between the Level of Low-Density Lipoprotein Cholesterol and Coronary Atherosclerosis in Patients Who Have Undergone Coronary Computed Tomography Angiography.

Authors:  Hiroko Inoue; Yuhei Shiga; Kohei Tashiro; Yuto Kawahira; Yasunori Suematsu; Yoshiaki Idemoto; Kanako Tano; Takashi Kuwano; Makoto Sugihara; Hiroaki Nishikawa; Yousuke Katsuda; Shin-Ichiro Miura
Journal:  Cardiol Res       Date:  2020-12-11

9.  Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes.

Authors:  Jose Luis Sánchez-Quesada; Irene Vinagre; Elena De Juan-Franco; Juan Sánchez-Hernández; Rosa Bonet-Marques; Francisco Blanco-Vaca; Jordi Ordóñez-Llanos; Antonio Pérez
Journal:  Cardiovasc Diabetol       Date:  2013-08-05       Impact factor: 9.951

10.  HDAC9 Variant Rs2107595 Modifies Susceptibility to Coronary Artery Disease and the Severity of Coronary Atherosclerosis in a Chinese Han Population.

Authors:  Xue-Bin Wang; Ya-di Han; Shrestha Sabina; Ning-Hua Cui; Shuai Zhang; Ze-Jin Liu; Cong Li; Fang Zheng
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.